ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,261 | -13.0% | 60,514 | 0.0% | 0.01% | -20.0% |
| Q2 2023 | $1,449 | +27.2% | 60,514 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $1,139 | +12.8% | 60,514 | -4.7% | 0.01% | 0.0% |
| Q4 2022 | $1,010 | -99.9% | 63,470 | -5.5% | 0.01% | 0.0% |
| Q3 2022 | $1,099,000 | +16.2% | 67,147 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $946,000 | -41.8% | 67,147 | 0.0% | 0.01% | -30.0% |
| Q1 2022 | $1,626,000 | +45.6% | 67,147 | +41.5% | 0.01% | +66.7% |
| Q4 2021 | $1,117,000 | -25.9% | 47,457 | -47.7% | 0.01% | -25.0% |
| Q3 2021 | $1,507,000 | -61.0% | 90,757 | -42.7% | 0.01% | -66.7% |
| Q2 2021 | $3,862,000 | +310.0% | 158,357 | +333.6% | 0.02% | +300.0% |
| Q1 2021 | $942,000 | -0.8% | 36,522 | +86.3% | 0.01% | -25.0% |
| Q2 2020 | $950,000 | – | 19,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |